Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

J&J Stays Within Price Pledge, But Average Doesn't Tell The Whole Story, Analyst Says

Mar 27 2018

• By Brenda Sandburg

Hand man doing finances and calculate on desk about cost at home office.

Related Content

PhRMA Sues To Block 'Unprecedented' California Price Reporting Law

Dec 12 2017

Fresh From The White House, J&J's Gorsky Talks Policy, Drug Pricing

Jan 25 2017

Janssen Emphasizes Average Net Price Decline As Transparency Momentum Builds In States

Mar 12 2018

J&J Shows Grace Under Pressure From Biosimilars And Other Threats

Jan 24 2018

Related Companies

Johnson & Johnson

AbbVie Inc.

IQVIA Holdings Inc.

Bausch Health Companies Inc.

Teva Pharmaceutical Industries Ltd.

Additional Topics

United States Pricing Strategies Market Access Commercial Policy BioPharmaceutical

More from Drug Pricing

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window